Skip to content
Roboearth – Lifestyle
Author:
Integrated BioPharma, Inc.
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2026
November 13, 2026
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2026
September 25, 2026
Integrated Biopharma’s Wholly-Owned Subsidiary, Manhattan Drug Company, Inc. Appoints Michael Richtmyer as Head of Operations
August 20, 2026